These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 15974895

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Acetylcholinesterase (AChE)--amyloid-beta-peptide complexes in Alzheimer's disease. the Wnt signaling pathway.
    Inestrosa NC, Urra S, Colombres M.
    Curr Alzheimer Res; 2004 Nov; 1(4):249-54. PubMed ID: 15975054
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Heparin-binding properties of the amyloidogenic peptides Abeta and amylin. Dependence on aggregation state and inhibition by Congo red.
    Watson DJ, Lander AD, Selkoe DJ.
    J Biol Chem; 1997 Dec 12; 272(50):31617-24. PubMed ID: 9395501
    [Abstract] [Full Text] [Related]

  • 5. Binding of proteases to fibrillar amyloid-beta protein and its inhibition by Congo red.
    Chander H, Chauhan A, Chauhan V.
    J Alzheimers Dis; 2007 Nov 12; 12(3):261-9. PubMed ID: 18057560
    [Abstract] [Full Text] [Related]

  • 6. Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide.
    Cottingham MG, Hollinshead MS, Vaux DJ.
    Biochemistry; 2002 Nov 19; 41(46):13539-47. PubMed ID: 12427014
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV, Semenov VE, Mukhamedyarov MA, Lushchekina SV, Kharlamova AD, Petukhova EO, Mikhailov AS, Podyachev SN, Saifina LF, Petrov KA, Minnekhanova OA, Zobov VV, Nikolsky EE, Masson P, Reznik VS.
    Int J Risk Saf Med; 2015 Nov 19; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Congo red inhibits proteoglycan and serum amyloid P binding to amyloid beta fibrils.
    Gupta-Bansal R, Brunden KR.
    J Neurochem; 1998 Jan 19; 70(1):292-8. PubMed ID: 9422374
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Acetylcholinesterase-Abeta complexes are more toxic than Abeta fibrils in rat hippocampus: effect on rat beta-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss.
    Reyes AE, Chacón MA, Dinamarca MC, Cerpa W, Morgan C, Inestrosa NC.
    Am J Pathol; 2004 Jun 19; 164(6):2163-74. PubMed ID: 15161650
    [Abstract] [Full Text] [Related]

  • 17. Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Brunhofer G, Fallarero A, Karlsson D, Batista-Gonzalez A, Shinde P, Gopi Mohan C, Vuorela P.
    Bioorg Med Chem; 2012 Nov 15; 20(22):6669-79. PubMed ID: 23062825
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.